Inhaled bronchodilator therapy with long-acting muscarinic antagonists (LAMAs) and long-
acting β2-agonists (LABAs) in combination is currently the mainstay of treatment for chronic …

Introduction Triple therapy in COPD is becoming increasingly important with the cumulative
documentation of its ability to reduce the risk of AECOPD. However, it must be established …

Although pharmacological treatment of COPD is codified in different guidelines and strategy
documents, there is abundant evidence of discrepancy between what they suggest and what …

Afavorable pharmacological interaction between long-acting β2 agonists, long-acting
muscarinic receptor antagonists, and inhaled corticosteroids (ICSs) explains why triple …

Background: bronchodilators are the key treatment for chronic obstructive pulmonary
disease (COPD), however, inhaled corticosteroids (ICSs)/long-acting β2-agonists (LABA) …

支气管扩张剂是指能对抗支气管收缩, 扩张支气管平滑肌(ASM), 逆转气道阻塞,
缓解气道狭窄的一类药物, 被广泛应用于支气管哮喘, 慢性阻塞性肺疾病(COPD) …

Objective To determine the clinical and economic consequences of inhaled corticosteroid
doses and particle size in patients on triple-inhalation therapy for COPD. Methods Patients …

Dual bronchodilation therapy represents the cornerstone for the treatment of COPD. A large
retrospective study reports that adding a second long-acting bronchodilator in patients with …

Лечение хронической обструктивной болезни легких постоянно совершенствуется, в
ее терапии широко используются бронхолитики длительного действия и …

Objective: To evaluate the efficacy of Magnesium Sulphate (MgSO4) with the conventional
treatment in acute exacerbation chronic obstructive pulmonary disease (AECOPD) Methods …